GuocoLand's Q2 profits plummeted 84% to $10.85m

It was hit by lower sales of completed condo units.

GuocoLand suffered from an 84% YoY decrease in its Q2 profits to $10.85m from $66m in the same period a year ago, an announcement revealed. The firm’s revenue also crashed 61% to $142.95m from $370.56m a year ago.

According to GuocoLand, the lower revenue was dragged by the higher progressive revenue recognition in Q1 as Sims Urban Oasis obtained its Temporary Occupation Permit in 2017.

Also read: GuocoLand profits plummeted 85% to $26.1m in Q1

“Lower sales of completed residential units were substantially brought down its inventory of completed unsold units in the past quarters also contributed to the drop in revenue,” it explained.

Meanwhile, in line with lower sales activities, administrative expenses fell by 28% to $19.6 m.

“The group has a balanced pipeline of mixed-use, commercial and residential projects, including the integrated mixed-use development Guoco Midtown which had its groundbreaking in November 2018,” it also noted.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare